• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与哺乳动物宿主适应性相关的拉沙病毒基因组变化。

Genomic changes of Lassa virus associated with mammalian host adaptation.

作者信息

Easterbrook Linda, Dong Xiaofeng, Smith Jack, Fotheringham Susan, Kempster Sarah, Hartley Catherine, Prince Tessa, Graham Victoria, Kennedy Emma, Findlay-Wilson Stephen, Crossley Lucy, Hewson Roger, Almond Neil, Hiscox Julian A, Dowall Stuart

机构信息

UK Health Security Agency (UKHSA), Porton Down, Salisbury, SP4 0JG, Wiltshire, UK.

Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, L3 5RF, UK.

出版信息

BMC Genomics. 2025 May 15;26(1):489. doi: 10.1186/s12864-025-11666-y.

DOI:10.1186/s12864-025-11666-y
PMID:40375146
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12079963/
Abstract

BACKGROUND

Lassa virus (LASV) causes a severe haemorrhagic fever in humans, with estimates of 100,000 to 300,000 infections annually in endemic regions and accounting for around 5000 deaths. The natural reservoir is the Mastomys rat, but through zoonotic transmissions humans are accidental hosts. Regular outbreaks continue to exert pressures on public health systems, with its ability to cause nosocomial infections posing risks to healthcare workers. It is a concern that larger outbreaks and introduction of LASV to new territories will intensify, including risk of adaptation to new mammalian host reservoirs.

RESULTS

To evaluate genetic changes in LASV during adaptation to a new host, a guinea pig model of infection was utilised. Initial infection with LASV stocks cultured from cell culture resulted in only mild or subclinical disease. To study the susceptibility in naïve animals, the virus was serially passaged which increased clinical signs during disease progression ultimately resulting in severe disease. An RNAseq and consensus mapping approach was undertaken to evaluate nucleotide changes in LASV genome from each animal at each passage.

CONCLUSIONS

During adaptation to guinea pigs, no significant new mutations occurred. Instead, a selection pressure on two genes of the L segment was observed resulting in their increased frequency in the genome population during passaging.

摘要

背景

拉沙病毒(LASV)可引发人类严重出血热,据估计,在流行地区每年有10万至30万例感染,约5000人死亡。其天然宿主是多乳鼠,但通过人畜共患病传播,人类成为偶然宿主。定期爆发的疫情持续给公共卫生系统带来压力,该病毒引发医院感染的能力对医护人员构成风险。令人担忧的是,更大规模的疫情爆发以及LASV传入新地区的情况将会加剧,包括适应新的哺乳动物宿主的风险。

结果

为评估LASV在适应新宿主过程中的基因变化,采用了豚鼠感染模型。用从细胞培养物中培养的LASV毒株进行初次感染,仅导致轻度或亚临床疾病。为研究未接触过该病毒的动物的易感性,病毒进行了连续传代,在疾病进展过程中临床症状加重,最终导致严重疾病。采用RNA测序和一致性图谱分析方法评估每一代动物LASV基因组中的核苷酸变化。

结论

在适应豚鼠的过程中,未出现显著的新突变。相反,观察到L片段的两个基因受到选择压力,导致其在传代过程中在基因组群体中的频率增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b5/12079963/8c3b820112ef/12864_2025_11666_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b5/12079963/025b5adc3579/12864_2025_11666_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b5/12079963/036ee2e5067c/12864_2025_11666_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b5/12079963/d99e9eb81515/12864_2025_11666_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b5/12079963/5a5c984a5ab1/12864_2025_11666_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b5/12079963/8c3b820112ef/12864_2025_11666_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b5/12079963/025b5adc3579/12864_2025_11666_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b5/12079963/036ee2e5067c/12864_2025_11666_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b5/12079963/d99e9eb81515/12864_2025_11666_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b5/12079963/5a5c984a5ab1/12864_2025_11666_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1b5/12079963/8c3b820112ef/12864_2025_11666_Fig5_HTML.jpg

相似文献

1
Genomic changes of Lassa virus associated with mammalian host adaptation.与哺乳动物宿主适应性相关的拉沙病毒基因组变化。
BMC Genomics. 2025 May 15;26(1):489. doi: 10.1186/s12864-025-11666-y.
2
Inoculation route-dependent Lassa virus dissemination and shedding dynamics in the natural reservoir - .天然储主中接种途径依赖性拉沙病毒的传播和脱落动力学。
Emerg Microbes Infect. 2021 Dec;10(1):2313-2325. doi: 10.1080/22221751.2021.2008773.
3
A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene.基于病毒糖蛋白基因密码子去优化的拉沙热减毒活疫苗。
mBio. 2020 Feb 25;11(1):e00039-20. doi: 10.1128/mBio.00039-20.
4
Lethal Infection of Lassa Virus Isolated from a Human Clinical Sample in Outbred Guinea Pigs without Adaptation.从未经适应的家兔中分离的人类临床样本中的拉沙病毒的致死性感染。
mSphere. 2019 Sep 25;4(5):e00428-19. doi: 10.1128/mSphere.00428-19.
5
A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region.基于基因间区重排的拉沙病毒活疫苗候选株。
mBio. 2020 Mar 24;11(2):e00186-20. doi: 10.1128/mBio.00186-20.
6
The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.广谱抗病毒药物法匹拉韦可在疾病发作后保护豚鼠免受致死性拉沙病毒感染。
Sci Rep. 2015 Oct 12;5:14775. doi: 10.1038/srep14775.
7
Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus.临床测序揭示拉沙病毒的起源与进化
Cell. 2015 Aug 13;162(4):738-50. doi: 10.1016/j.cell.2015.07.020.
8
Geographic distribution and genetic characterization of Lassa virus in sub-Saharan Mali.撒哈拉以南马里地区拉沙病毒的地理分布与基因特征
PLoS Negl Trop Dis. 2013 Dec 5;7(12):e2582. doi: 10.1371/journal.pntd.0002582. eCollection 2013.
9
Sequence variability and geographic distribution of Lassa virus, Sierra Leone.塞拉利昂拉沙病毒的序列变异性和地理分布
Emerg Infect Dis. 2015 Apr;21(4):609-18. doi: 10.3201/eid2104.141469.
10
Lassa virus in novel hosts: insights into the epidemiology of lassa virus infections in southern Nigeria.新型宿主中的拉沙病毒:尼日利亚南部拉沙病毒感染的流行病学新见解。
Emerg Microbes Infect. 2024 Dec;13(1):2294859. doi: 10.1080/22221751.2023.2294859. Epub 2024 Jan 22.

本文引用的文献

1
Lassa fever research priorities: towards effective medical countermeasures by the end of the decade.拉沙热研究重点:在十年内实现有效的医疗对策。
Lancet Infect Dis. 2024 Nov;24(11):e696-e706. doi: 10.1016/S1473-3099(24)00229-9. Epub 2024 Jul 1.
2
An Outbred Guinea Pig Disease Model for Lassa Fever Using a Host-Adapted Clade III Nigerian Lassa Virus.一种使用宿主适应的尼日利亚 III 型拉沙病毒的杂交豚鼠拉沙热疾病模型。
Viruses. 2023 Mar 17;15(3):769. doi: 10.3390/v15030769.
3
Understanding the transmission pathways of Lassa fever: A mathematical modeling approach.
了解拉沙热的传播途径:一种数学建模方法。
Infect Dis Model. 2022 Nov 30;8(1):27-57. doi: 10.1016/j.idm.2022.11.010. eCollection 2023 Mar.
4
Machupo Virus with Mutations in the Transmembrane Domain and Glycosylation Sites of the Glycoprotein Is Attenuated and Immunogenic in Animal Models of Bolivian Hemorrhagic Fever.带有跨膜区和糖基化位点突变的马丘波病毒在玻利维亚出血热动物模型中减毒并具有免疫原性。
J Virol. 2022 Apr 27;96(8):e0020922. doi: 10.1128/jvi.00209-22. Epub 2022 Mar 28.
5
Lassa virus glycoprotein complex review: insights into its unique fusion machinery.拉沙病毒糖蛋白复合物综述:深入了解其独特的融合机制。
Biosci Rep. 2022 Feb 25;42(2). doi: 10.1042/BSR20211930.
6
The adaptation of SARS-CoV-2 to humans.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)对人类的适应性。
Mem Inst Oswaldo Cruz. 2022 Jan 10;116:e210127. doi: 10.1590/0074-02760210127. eCollection 2022.
7
Conformational changes in Lassa virus L protein associated with promoter binding and RNA synthesis activity.与启动子结合和 RNA 合成活性相关的拉沙病毒 L 蛋白构象变化。
Nat Commun. 2021 Dec 2;12(1):7018. doi: 10.1038/s41467-021-27305-5.
8
Pathogenicity and virulence mechanisms of Lassa virus and its animal modeling, diagnostic, prophylactic, and therapeutic developments.拉沙病毒的致病性和毒力机制及其动物模型、诊断、预防和治疗的发展。
Virulence. 2021 Dec;12(1):2989-3014. doi: 10.1080/21505594.2021.2000290.
9
Infection pattern, case fatality rate and spread of Lassa virus in Nigeria.尼日利亚拉沙病毒的感染模式、病死率和传播情况。
BMC Infect Dis. 2021 Feb 5;21(1):149. doi: 10.1186/s12879-021-05837-x.
10
Monitoring of Lassa virus infection in suspected and confirmed cases in Ondo State, Nigeria.尼日利亚翁多州疑似和确诊拉沙热病例的拉沙病毒感染监测。
Pan Afr Med J. 2020 Aug 6;36:253. doi: 10.11604/pamj.2020.36.253.22104. eCollection 2020.